UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A AMENDMENT NO. 1 /X/ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1998 Commission File Number 0-9314 ACCESS PHARMACEUTICALS, INC. ------------------------------------------------------ (Exact name of registrant as specified in its charter) Delaware 83-0221517 - ------------------------ -------------------------- (State of Incorporation) (I.R.S. Employer I.D. No.) 2600 Stemmons Frwy, Suite 176, Dallas, TX 75207 ----------------------------------------------- (Address of principal executive offices) Telephone Number (214) 905-5100 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirement for the past 90 days. Yes X No ----- ----- Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. Common stock outstanding as of August 14, 1998 3,426,695 shares, $0.01 par value --------------- --------- PART II -- OTHER INFORMATION ITEM 6 EXHIBITS AND REPORTS ON FORM 8-K Exhibits: 3.8 Certificate of Amendment of Certificate of Incorporation filed June 18, 1998 (previously filed) 10.13 Agreement between Access Pharmaceuticals, Inc. and Block Drug Company, Inc. (Confidential Treatment Requested) 10.14 Sales Agency Agreement (previously filed) 10.15 Registration Rights Agreement (previously filed) 27.1 Financial Data Schedule (previously filed) Reports on Form 8-K: None SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Amendment No. 1 to be signed on its behalf by the undersigned, thereunto duly authorized. ACCESS PHARMACEUTICALS, INC. Date: December 4, 1998 By: /s/ Kerry P. Gray ----------------- ------------------ Kerry P. Gray President and Chief Executive Officer (Principal Executive Officer) Date: December 4, 1998 By: /s/ Stephen B. Thompson ----------------- ------------------------ Stephen B. Thompson Chief Financial Officer (Principal Financial and Accounting Officer)